224 related articles for article (PubMed ID: 23455991)
21. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
[TBL] [Abstract][Full Text] [Related]
22. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI.
Vos S; van Rossum I; Burns L; Knol D; Scheltens P; Soininen H; Wahlund LO; Hampel H; Tsolaki M; Minthon L; Handels R; L'Italien G; van der Flier W; Aalten P; Teunissen C; Barkhof F; Blennow K; Wolz R; Rueckert D; Verhey F; Visser PJ
Neurobiol Aging; 2012 Oct; 33(10):2272-81. PubMed ID: 22264648
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
24. Education plays a different role in Frontotemporal Dementia and Alzheimer's disease.
Borroni B; Alberici A; Agosti C; Premi E; Padovani A
Int J Geriatr Psychiatry; 2008 Aug; 23(8):796-800. PubMed ID: 18172915
[TBL] [Abstract][Full Text] [Related]
25. Impact of white matter lesions and cognitive deficits on conversion from mild cognitive impairment to Alzheimer's disease.
Defrancesco M; Marksteiner J; Deisenhammer E; Kemmler G; Djurdjevic T; Schocke M
J Alzheimers Dis; 2013; 34(3):665-72. PubMed ID: 23254639
[TBL] [Abstract][Full Text] [Related]
26. The closing-in phenomenon in constructional tasks in dementia and mild cognitive impairment.
De Lucia N; Grossi D; Milan G; Trojano L
Neuropsychology; 2020 Feb; 34(2):168-175. PubMed ID: 31566391
[TBL] [Abstract][Full Text] [Related]
27. White matter disease independently predicts progression from mild cognitive impairment to Alzheimer's disease in a clinic cohort.
Prasad K; Wiryasaputra L; Ng A; Kandiah N
Dement Geriatr Cogn Disord; 2011; 31(6):431-4. PubMed ID: 21757908
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-β Isoforms for Early and Differential Dementia Diagnosis.
Struyfs H; Van Broeck B; Timmers M; Fransen E; Sleegers K; Van Broeckhoven C; De Deyn PP; Streffer JR; Mercken M; Engelborghs S
J Alzheimers Dis; 2015; 45(3):813-22. PubMed ID: 25633670
[TBL] [Abstract][Full Text] [Related]
29. Overlap between frontotemporal dementia and Alzheimer's disease: cerebrospinal fluid pattern and neuroimaging study.
Padovani A; Premi E; Pilotto A; Gazzina S; Cosseddu M; Archetti S; Cancelli V; Paghera B; Borroni B
J Alzheimers Dis; 2013; 36(1):49-55. PubMed ID: 23568100
[TBL] [Abstract][Full Text] [Related]
30. [Apathy in frontotemporal dementia and Alzheimer's disease: are there distinct profiles?].
Derouesné C; Lacomblez L; Fiori N; Gély-Nargeot MC; Bungener C
Geriatr Psychol Neuropsychiatr Vieil; 2012 Mar; 10(1):107-15. PubMed ID: 22414405
[TBL] [Abstract][Full Text] [Related]
31. Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.
Seeburger JL; Holder DJ; Combrinck M; Joachim C; Laterza O; Tanen M; Dallob A; Chappell D; Snyder K; Flynn M; Simon A; Modur V; Potter WZ; Wilcock G; Savage MJ; Smith AD
J Alzheimers Dis; 2015; 44(2):525-39. PubMed ID: 25391385
[TBL] [Abstract][Full Text] [Related]
32. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
33. Is hippocampal volume a good marker to differentiate Alzheimer's disease from frontotemporal dementia?
de Souza LC; Chupin M; Bertoux M; Lehéricy S; Dubois B; Lamari F; Le Ber I; Bottlaender M; Colliot O; Sarazin M
J Alzheimers Dis; 2013; 36(1):57-66. PubMed ID: 23542864
[TBL] [Abstract][Full Text] [Related]
34. Mild cognitive impairment: clinical and imaging profile in a memory clinic setting in India.
Alladi S; Shailaja M; Mridula KR; Haritha CA; Kavitha N; Khan SA; Divyaraj G; Kaul S
Dement Geriatr Cogn Disord; 2014; 37(1-2):113-24. PubMed ID: 24135787
[TBL] [Abstract][Full Text] [Related]
35. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
[TBL] [Abstract][Full Text] [Related]
36. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
Hänggi J; Streffer J; Jäncke L; Hock C
J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
[TBL] [Abstract][Full Text] [Related]
37. Differentiation of Alzheimer's Disease from Frontotemporal Dementia and Mild Cognitive Impairment Based on Arterial Spin Labeling Magnetic Resonance Imaging: A Pilot Cross-Sectional Study from PUMCH Dementia Cohort.
Mao C; You H; Hou B; Chu S; Jin W; Huang X; Shang L; Feng F; Peng B; Gao J
J Alzheimers Dis; 2023; 93(2):509-519. PubMed ID: 37038812
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive visual rating scale of brain magnetic resonance imaging: application in elderly subjects with Alzheimer's disease, mild cognitive impairment, and normal cognition.
Jang JW; Park SY; Park YH; Baek MJ; Lim JS; Youn YC; Kim S
J Alzheimers Dis; 2015; 44(3):1023-34. PubMed ID: 25380589
[TBL] [Abstract][Full Text] [Related]
39. Clinical relevance of specific T-cell activation in the blood and cerebrospinal fluid of patients with mild Alzheimer's disease.
Lueg G; Gross CC; Lohmann H; Johnen A; Kemmling A; Deppe M; Groger J; Minnerup J; Wiendl H; Meuth SG; Duning T
Neurobiol Aging; 2015 Jan; 36(1):81-9. PubMed ID: 25277040
[TBL] [Abstract][Full Text] [Related]
40. Relationship between β-Secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease.
Alcolea D; Carmona-Iragui M; Suárez-Calvet M; Sánchez-Saudinós MB; Sala I; Antón-Aguirre S; Blesa R; Clarimón J; Fortea J; Lleó A
J Alzheimers Dis; 2014; 42(1):157-67. PubMed ID: 24820015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
